Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2007-02-27
2007-02-27
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S400000, C424S457000, C514S002600, C514S003100, C514S078000, C514S169000, C514S177000, C514S179000, C514S772000, C514S806000, C514S807000, C514S808000, C514S866000, C514S970000
Reexamination Certificate
active
10749914
ABSTRACT:
A stable composition of a drug comprising a carrier having a phosphatidylcholine component which entraps the drug is applied to the skin for transdermal delivery of the drug.
REFERENCES:
patent: 4174296 (1979-11-01), Kass
patent: 4624665 (1986-11-01), Nuwayser
patent: 4687661 (1987-08-01), Kikuchi et al.
patent: 5120561 (1992-06-01), Silva et al.
patent: 5674912 (1997-10-01), Martin
patent: 5874479 (1999-02-01), Martin
patent: 5985298 (1999-11-01), Brieva et al.
patent: 6165500 (2000-12-01), Cevc
patent: 6211250 (2001-04-01), Tomlinson et al.
patent: 6214375 (2001-04-01), Modi
patent: 6294192 (2001-09-01), Patel et al.
patent: 6521250 (2003-02-01), Meconi et al.
patent: 6538061 (2003-03-01), Chaiyawat et al.
patent: 6555573 (2003-04-01), Rosenbloom
patent: 2004/0191305 (2004-09-01), Perricone et al.
patent: WO 01/01963 (2001-01-01), None
Agarwal, R. and Katare, O.P., Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes,Pharmaceutical Technology, Nov. 2002, p. 48-60.
Benson, H. and Prankerd, R, “Optimization of Drug Delivery 4. Transdermal Drug Delivery,”Aus J Hosp Pharm, 27(6): 441-448 (1997).
Bhattacharjee, Y., “More Than the Patch: New Ways to Take Medicine Via Skin,”New York Times, Jul. 2, 2002, p. F5.
Brannon-Peppas, L., “Polymers in Controlled Drug Delivery,”Medical Plastics and Biomaterials Magazine, Nov. 1997.
Cevc, G. et al, Transdermal Drug Carriers: Basic Properties, Optimization and Transfer Efficiency in the Case of Epicutaneously Applied Peptides,Journal of Controlled Release36: 3-16 (1995).
Chetty, D. and Chien, Y., Novel Methods of Insulin Delivery: An Update,Critical Reviews in Therapeutic Drug Carrier Systems, 15(6): 629-670 (1998).
Christie, W.W., Phosphatidylcholine and Related Lipids, www.lipid.co.uk, May 5, 2003.
Daddona, P., Recent Advances in Peptide, Protein and Macromolecule Drug Delivery,Current Opinion in Drug Discovery&Development, 2(2): 168-171 (19999).
Daniels, R., “Galenic Principles of Modern Skin Care Products,”Skin Care Forum, Issue 25, Apr. 2001.
Guo et al, “Transdermal Delivery of Insulin in Mice by Using Lecithin Vesicles as a Carrier,”Drug Delivery, 7:113-116 (2000).
Mitragotri, S., “Synergistic Effect of Enhancers for Transdermal Drug Delivery,”Pharmaceutical Research, 17(11):1354-1359 (2000).
Patki, V.P. and Jagasia, S.H., “Progress Made in Non-Invasive Insulin Delivery,”Indian Journal of Pharmacology, 28:143-151 (1996).
Trehan, A. and Ali, A., “Recent Approaches in Insulin Delivery,”Drug Development and Industrial Pharmacy, 24(7): 589-97 (1998).
Perricone Nicholas V.
Potini Chim
Arnold Ernst V
Perricone Nicholas V.
Richter Johann
St. Onge Steward Johnston & Reens LLC
LandOfFree
Stable topical drug delivery compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable topical drug delivery compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable topical drug delivery compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3812310